KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Net Income towards Common Stockholders (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -61.60%
Dec 31, 2025 865.43%
Sep 30, 2025 -80.02%
Jun 30, 2025 -27.00%
Mar 31, 2025 5,704.35%
Dec 31, 2024 -101.47%
Sep 30, 2024 13.91%
Jun 30, 2024 0.07%
Mar 31, 2024 66.50%
Dec 31, 2023 -53.73%
Sep 30, 2023 -12.14%
Jun 30, 2023 2,189.69%
Mar 31, 2023 -103.92%
Dec 31, 2022 -37.45%
Sep 30, 2022 325.86%
Jun 30, 2022 -79.35%
Mar 31, 2022 11.08%
Dec 31, 2021 27.20%
Sep 30, 2021 327.42%
Jun 30, 2021 -78.94%
Mar 31, 2021 20,676.47%
Dec 31, 2020 -99.26%
Sep 30, 2020 400.66%
Jun 30, 2020 -125.35%
Mar 31, 2020 7.46%
Dec 31, 2019 48.67%
Sep 30, 2019 154.25%
Jun 30, 2019 -69.83%
Mar 31, 2019 234.50%
Dec 31, 2018 -166.47%
Sep 30, 2018 38.53%
Jun 30, 2018 -28.75%
Mar 31, 2018 5,251.92%
Dec 31, 2017 -96.81%
Sep 30, 2017 -14.83%
Jun 30, 2017 11.92%
Mar 31, 2017 23.01%
Dec 31, 2016 -12.95%
Sep 30, 2016 -0.75%
Jun 30, 2016 18.91%
Mar 31, 2016 -10.74%
Dec 31, 2015 22.44%
Sep 30, 2015 -9.30%
Jun 30, 2015 33.66%
Mar 31, 2015 226.17%
Dec 31, 2014 -260.08%
Sep 30, 2014 -53.92%
Jun 30, 2014 12.04%
Mar 31, 2014 -13.12%
Dec 31, 2013 17.01%
Sep 30, 2013 -9.74%
Jun 30, 2013 10.33%
Mar 31, 2013 -37.14%
Dec 31, 2012 -2.84%
Sep 30, 2012 25.10%
Jun 30, 2012 43.49%